Hype, Hope and a Coffee Order BioNSW's Commercialisation Breakfast put an IP specialist, two investors, a medtech industry veteran and clinician, together with a university dean in one room to sort genuine innovation from noise. The line that stuck wasn't about a technology at all. “Go and buy people coffee. Make friends. Put yourself in their line of sight.” That was Mark Flynn's advice to a room full of researchers and founders on 8 September, and it had nothing to do with

The latest instalment of BioNSW's BioInvest Catalyst Dinner series was held on 21 July 2026. The sell out dinner brought together life sciences leaders and investors at The Oriana Sydney, against the backdrop of Sydney Harbour Bridge and the Opera House, for an evening focused squarely on one goal: unlocking capital for the NSW biotech sector. As BioNSW Investment Committee Chair Christian Toouli reflected afterwards, “It was a fabulous event: an engaging format, a great venu

A packed room at EY's Sydney office on July 7th 2026 put one point beyond doubt: the Life Sciences sector is not divided on the proposed RDTI and CGT changes, rather, it is aligned, and it is not staying quiet.BioNSW partnered with EY to host a Federal Budget Briefing on the proposed changes to the Research and Development Tax Incentive (RDTI) and Capital Gains Tax (CGT) settings. The turnout reflected how directly these settings touch the sector's ability to fund discovery,

August saw BioNSW kick-off the Financial Year with a retrospective look at NSW's delegation to the 2024 BIO Conference. At an event...

⏰ We're excited to announce, in collaboration with Investment NSW and kindly hosted by King & Wood Mallesons, a Post-BIO Briefing event...